Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
58.10
+0.13 (0.22%)
Aug 11, 2026, 10:52 AM EDT - Market open
Royalty Pharma Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,536 | 2,378 | 2,264 | 2,355 | 2,237 | 2,289 |
Revenue Growth | 10.01% | 5.06% | -3.86% | 5.24% | -2.28% | 7.87% |
Gross Profit Gross Profit Growth | 2,430 | 2,674 | 1,531 | 1,794 | 1,333 | 1,837 |
Operating Income Operating Income Growth | 1,512 | 1,560 | 1,292 | 1,492 | 307.07 | 1,431 |
Net Income Net Income Growth | 815 | 770.95 | 858.98 | 1,135 | 42.83 | 619.73 |
Earnings Per Share EPS Growth | 1.88 | 1.78 | 1.91 | 2.53 | 0.10 | 1.49 |
EPS Growth | -18.26% | -6.81% | -24.51% | 2430.00% | -93.29% | 12.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cystic Fibrosis Franchise Cystic Fibrosis Franchise Growth | 855.89 | 828.18 | 826.21 | 852.31 | 808.95 | 762.89 |
Evrysdi Evrysdi Growth | 221.14 | 206.97 | 224.43 | 97.74 | - | - |
Trelegy Trelegy Growth | 160.44 | 154.1 | 146.92 | 128.05 | 57.93 | - |
Tremfya Tremfya Growth | 191.36 | 152.94 | 147.14 | 149.72 | 109.8 | 16.71 |
Voranigo Voranigo Growth | 172.98 | 154.42 | 46.15 | - | - | - |
Tysabri Tysabri Growth | 111.38 | 116.88 | 124.82 | 167.54 | 207.16 | 211.42 |
Other Products Other Products Growth | 691.07 | 647.67 | 633.76 | 629.24 | 630.33 | 507.52 |
Other Royalty Income and Other Royalty Income and Growth | 131.74 | 117.04 | 114.15 | 156.8 | 112.12 | 224.38 |
Revenue (Total) Revenue (Total) Growth | 2,536 | 2,378 | 2,264 | 2,355 | 2,237 | 2,289 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 811.99 | 618.7 | 929.03 | 477.01 | 1,735 | 2,123 |
Total Debt Total Debt Growth | 8,962 | 8,951 | 7,612 | 6,135 | 7,116 | 7,096 |
Net Cash (Debt) Net Cash Growth | -8,150 | -8,332 | -6,683 | -5,658 | -5,381 | -4,973 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -14.62 | -14.76 | -11.25 | -9.39 | -12.29 | -11.99 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,976 | 2,490 | 2,769 | 2,988 | 2,144 | 2,018 |
Free Cash Flow Free Cash Flow Growth | 2,976 | 2,490 | 2,769 | 2,988 | 2,144 | 2,018 |
Free Cash Flow Growth | 23.70% | -10.08% | -7.32% | 39.36% | 6.27% | -0.84% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 95.82% | 112.44% | 67.64% | 76.19% | 59.58% | 80.22% |
Operating Margin | 59.61% | 65.58% | 57.10% | 63.37% | 13.73% | 62.49% |
Pretax Margin | 53.23% | 55.68% | 58.79% | 72.20% | 10.28% | 54.21% |
Profit Margin | 53.23% | 55.68% | 58.79% | 72.20% | 10.28% | 54.21% |
FCF Margin | 117.37% | 104.69% | 122.33% | 126.89% | 95.83% | 88.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.940 | 0.880 | 0.840 | 0.800 | 0.760 | 0.680 |
Dividend Per Share Growth | 6.32% | 4.76% | 5.00% | 5.26% | 11.77% | 126.67% |
Dividend Yield | 1.62% | 2.28% | 3.29% | 2.85% | 1.93% | 1.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.20 | 21.71 | 13.36 | 11.10 | 395.20 | 26.75 |
Forward PE | 10.79 | 7.70 | 6.10 | 7.47 | 10.32 | 13.00 |
P/FCF Ratio | 11.20 | 6.65 | 4.11 | 4.20 | 8.17 | 8.55 |
PS Ratio | 13.14 | 6.96 | 5.03 | 5.33 | 7.83 | 7.54 |